Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
7.85
-0.04 (-0.51%)
At close: Sep 5, 2025, 4:00 PM
7.86
+0.01 (0.13%)
After-hours: Sep 5, 2025, 7:49 PM EDT
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 394 employees as of December 31, 2024. The number of employees increased by 17 or 4.51% compared to the previous year.
Employees
394
Change (1Y)
17
Growth (1Y)
4.51%
Revenue / Employee
$624,429
Profits / Employee
-$81,216
Market Cap
1.27B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394 | 17 | 4.51% |
| Dec 31, 2023 | 377 | 22 | 6.20% |
| Dec 31, 2022 | 355 | 61 | 20.75% |
| Dec 31, 2021 | 294 | 114 | 63.33% |
| Dec 31, 2020 | 180 | -22 | -10.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
XERS News
- 17 hours ago - Xeris In Recorlev-Fuelled Growth: Why I Choose To Buy - Seeking Alpha
- 11 days ago - Xeris Announces Orange Book Listing of U.S. Patent for Recorlev® - Business Wire
- 4 weeks ago - Xeris Biopharma Holdings, Inc. (XERS) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Xeris Biopharma Reports Record Financial Results for the Second Quarter 2025 and Raises Full Year Revenue Guidance - Business Wire
- 5 weeks ago - Xeris Biopharma to Report Second Quarter 2025 Financial Results on August 7, 2025 - Business Wire
- 2 months ago - Xeris Biopharma: Great Numbers, Great Technologies, And Suitable For Long-Term Investing - Seeking Alpha
- 3 months ago - Xeris Unveils Strategy for Long-Term Growth and Value Creation at 2025 Analyst & Investor Day - Business Wire
- 3 months ago - Xeris Announces Details for Analyst & Investor Day - Business Wire